252 related articles for article (PubMed ID: 25670913)
1. New and emerging therapeutic options for malignant pleural mesothelioma: review of early clinical trials.
Kotova S; Wong RM; Cameron RB
Cancer Manag Res; 2015; 7():51-63. PubMed ID: 25670913
[TBL] [Abstract][Full Text] [Related]
2. Malignant Pleural Mesothelioma: State-of-the-Art on Current Therapies and Promises for the Future.
Nicolini F; Bocchini M; Bronte G; Delmonte A; Guidoboni M; Crinò L; Mazza M
Front Oncol; 2019; 9():1519. PubMed ID: 32039010
[TBL] [Abstract][Full Text] [Related]
3. Emerging New Targets in Systemic Therapy for Malignant Pleural Mesothelioma.
Yun KM; Bazhenova L
Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38610930
[TBL] [Abstract][Full Text] [Related]
4. Patterns of failure following surgical resection for malignant pleural mesothelioma.
Jänne PA; Baldini EH
Thorac Surg Clin; 2004 Nov; 14(4):567-73. PubMed ID: 15559064
[TBL] [Abstract][Full Text] [Related]
5. The Evolving Role of Immune-Checkpoint Inhibitors in Malignant Pleural Mesothelioma.
Borgeaud M; Kim F; Friedlaender A; Lococo F; Addeo A; Minervini F
J Clin Med; 2023 Feb; 12(5):. PubMed ID: 36902544
[TBL] [Abstract][Full Text] [Related]
6. Emerging therapies in malignant pleural mesothelioma.
Cinausero M; Rihawi K; Cortiula F; Follador A; Fasola G; Ardizzoni A
Crit Rev Oncol Hematol; 2019 Dec; 144():102815. PubMed ID: 31670225
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy for malignant pleural mesothelioma: current status and future directions.
Dozier J; Zheng H; Adusumilli PS
Transl Lung Cancer Res; 2017 Jun; 6(3):315-324. PubMed ID: 28713676
[TBL] [Abstract][Full Text] [Related]
8. Emerging Treatments for Malignant Pleural Mesothelioma: Where Are We Heading?
Cantini L; Hassan R; Sterman DH; Aerts JGJV
Front Oncol; 2020; 10():343. PubMed ID: 32226777
[TBL] [Abstract][Full Text] [Related]
9. Novel immunotherapy clinical trials in malignant pleural mesothelioma.
Tano ZE; Chintala NK; Li X; Adusumilli PS
Ann Transl Med; 2017 Jun; 5(11):245. PubMed ID: 28706913
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of pleural effusion mesothelin in malignant pleural mesothelioma.
Yamada S; Tabata C; Tabata R; Fukuoka K; Nakano T
Clin Chem Lab Med; 2011 Oct; 49(10):1721-6. PubMed ID: 21692685
[TBL] [Abstract][Full Text] [Related]
11. Cellular Immunotherapy and Locoregional Administration of CAR T-Cells in Malignant Pleural Mesothelioma.
Belderbos RA; Vroman H; Aerts JGJV
Front Oncol; 2020; 10():777. PubMed ID: 32582537
[TBL] [Abstract][Full Text] [Related]
12. Radio-immunotherapy and chemo-immunotherapy as a novel treatment paradigm in malignant pleural mesothelioma.
Wu L; de Perrot M
Transl Lung Cancer Res; 2017 Jun; 6(3):325-334. PubMed ID: 28713677
[TBL] [Abstract][Full Text] [Related]
13. Malignant pleural mesothelioma.
Chen SE; Pace MB
Am J Health Syst Pharm; 2012 Mar; 69(5):377-85. PubMed ID: 22345416
[TBL] [Abstract][Full Text] [Related]
14. Malignant pleural mesothelioma: surgical roles and novel therapies.
Pass HI
Clin Lung Cancer; 2001 Nov; 3(2):102-17. PubMed ID: 14659025
[TBL] [Abstract][Full Text] [Related]
15. A phase II study of intrapleural immuno-chemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy and long-term sub-cutaneous IL-2 in stage II-III malignant pleural mesothelioma.
Lucchi M; Chella A; Melfi F; Dini P; Ambrogi M; Fino L; Fontanini G; Mussi A
Eur J Cardiothorac Surg; 2007 Mar; 31(3):529-33; discussion 533-4. PubMed ID: 17188885
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA gene expression signatures in long-surviving malignant pleural mesothelioma patients.
Lin RC; Kirschner MB; Cheng YY; van Zandwijk N; Reid G
Genom Data; 2016 Sep; 9():44-9. PubMed ID: 27408810
[TBL] [Abstract][Full Text] [Related]
17. Surgical treatment of malignant pleural mesothelioma: a review.
van Ruth S; Baas P; Zoetmulder FA
Chest; 2003 Feb; 123(2):551-61. PubMed ID: 12576380
[TBL] [Abstract][Full Text] [Related]
18. Intraoperative adjuncts for malignant pleural mesothelioma.
Chan WH; Sugarbaker DJ; Burt BM
Transl Lung Cancer Res; 2017 Jun; 6(3):285-294. PubMed ID: 28713674
[TBL] [Abstract][Full Text] [Related]
19. Malignant mesothelioma 2008.
Zervos MD; Bizekis C; Pass HI
Curr Opin Pulm Med; 2008 Jul; 14(4):303-9. PubMed ID: 18520263
[TBL] [Abstract][Full Text] [Related]
20. Management options for malignant pleural mesothelioma: clinical and cost considerations.
Goudar RK
Drugs; 2007; 67(8):1149-65. PubMed ID: 17521217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
